Selected Conference Presentations of Laboratory Endocrinology

2019

Korbut AI, Vinogradov IV, Klimontov VV. Clinical phenotypes and biomarkers of non-albuminuric and albuminuric patterns of chronic kidney disease in subjects with type 2 diabetes. / 55th Annual Meeting of the European Association for the Study of Diabetes. Barcelona, Spain, 17-20 September 2019.

Koroleva EA, Khapaev RS, Lykov AP, Klimontov VV. Serum levels of calponin 1, relaxin and l-citrulline in subjects with type 2 diabetes: the relationships with carotid atherosclerosis parameters. / 55th Annual Meeting of the European Association for the Study of Diabetes. Barcelona, Spain, 17-20 September 2019.

Klimontov V, Vigel A, Myakina N. BU-01034: Glucose variability and glycation in subjects with type 1 diabetes: the relationships with chronic kidney disease. / IDF Diabetes Congress 2019. Busan, South Korea, 2-6 December 2019, P-0672.

Klimontov V. How is the latest real-world evidence on insulin glargine 300 U/ml complementing RCTs? / International Diabetes & Cardiovascular Summit. Moscow, 26-28 June 2019.

Klimontov V, Blumer I. Patient journey on basal insulin. / International Diabetes & Cardiovascular Summit. Moscow, 26-28 June 2019.

Klimontov V. Digital and Precision Medicine. Diabetes as an Application Point. / The Eleventh International Young Scientists School. Novosibirsk, 24-27 June 2019

2018

Lazarev M.M., V.V. Klimontov, A.A. Makhotin, D.M. Bulumbaeva, E.A. Koroleva, A.Y. Letyagin. Quantitative ultrasound characteristics of insulin-induced lipohypertrophy in subjects with diabetes. / 54th Annual Meeting of the European Association for the Study of Diabetes. Berlin, 1-5 October 2019.

Klimontov V.V., Bulumbaeva D.M., Lykov A.P., Fazullina O.N., Bgatova N.P., Pfeiffer A.F.H., Pivovarova O., Rudovich N. Circulating WISP1/CCN4 is associated with body fat distribution and adipose tissue dysfunction in subjects with type 2 diabetes. / 54th Annual Meeting of the European Association for the Study of Diabetes. Berlin, 1-5 October 2019.

Korbut A.I., Klimontov V.V., Taskayeva Yu.S., Bgatova N.P., Zav’yalov E.L. Empagliflozin and linagliptin alleviate podocyte injury and activate glomerular autophagy in a model of type 2 diabetes. / 54th Annual Meeting of the European Association for the Study of Diabetes. Berlin, 1-5 October 2019.

Myakina NE, Lotz IJu, Klimontov VV. Continuous Glucose Monitoring Data Analysis in Insulin-Treated Type 1 And Type 2 Diabetic Subjects with the Use of Original Software. / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology and Biomedicine (BGRS/SB). Novosibirsk, 2018. – P. 24-27. doi: 10.1109/CSGB.2018.8544878.

Voytko M, Pospelova TI, Klimontov VV, Fazullina ON. Bone mineral density changes in patients with Hodgkin's lymphoma. / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology (BGRS/SB). Novosibirsk, 2018. – P. 18-19. doi: 10.1109/CSGB.2018.8544777.

Korbut A, Klimontov V, Taskaeva Ju, Bgatova N, Zavjalov E. Empagliflozin and linagliptin ameliorate podocyte injury and enhance autophagy in a model of type 2 diabetic nephropathy. / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology (BGRS/SB). Novosibirsk, 2018. – P. 28-32. doi: 10.1109/CSGB.2018.8544785.

Bulumbaeva DM, Klimontov VV, Bgatova NP, Taskaeva JuS, Fazullina ON, Orlov NB, Konenkov VI, Soluyanov MYu, Savchenko SV. Serum Levels of Adipokines in Type 2 Diabetic Subjects: the Relationships with Adipose Tissue Distribution and Microvasculature. / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology (BGRS/SB). Novosibirsk, 2018. – P. 81-84. doi: 10.1109/CSGB.2018.8544862.

Klimontov VV, Bulumbaeva DM, Lykov AP, Fazullina ON, Bgatova NP, Orlov NB, Pfeiffer AFHP, Pivovarova O, Rudovich N. Serum levels of WISP1/CCN4 in subjects with type 2 diabetes: the relationships with body fat distribution and adipose tissue dysfunction. / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology (BGRS/SB). Novosibirsk, 2018. – P. 85-87. doi: 10.1109/CSGB.2018.8544817.

Klimontov VV, Koroleva EA, Fazullina ON. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes / Processings of 11th International Multiconference Bioinformatics of Genome Regulation and Structure / System Biology (BGRS/SB). Novosibirsk, 2018. – P. 100-101. doi: 10.1109/CSGB.2018.8544728.

2017

1. Bulumbaeva DM, Klimontov VV, Tyan NV, Orlov NB, Konenkov VI. Serum levels of angiogenic growth factors in subjects with type 2 diabetes with and without peripheral artery disease. 53th Annual Meeting of theEuropean Association for the Study of Diabetes. Lisbon, Portugal, 11-15 September 2017: PP 1142.

2. Korbut AI, Klimontov VV, Bgatova NP, Gavrilova YS, Ischenko IY, Orlov NB, Dozenko AS, Zavjalov EI. Linagliptin alleviates podocyte injury and enhances glomerular nephrin expression in a model of type 2 diabetes. 53th Annual Meeting of theEuropean Association for the Study of Diabetes. Lisbon, Portugal, 11-15 September 2017: PP 1194.

3. Fazullina ON, Klimontov VV, Konenkov VI, Shevchenko AV, Prokofiev VF, Tsepilov YA. Modeling the risk of osteopenia and osteoporosis in postmenopausal women with type 2 diabetes on the sets of clinical and immunogenetic parameters. 2017 International MultiConference on Engineering, Computer and Information Sciences (SIBIRCON). Novosibirsk, Russia, 18-24 September 2017

2016

1. Klimontov VV, Tyan NV, Orlov NB, Shevchenko AV. Serum levels of VEGF family angiogenic factors and VEGF-A gene polymorphism are associated with coronary artery disease in type 2 diabetic patients. 76th Scientific Session of American Diabetes Association. New Orleans, USA, June 10-14, 2016.

2. Klimontov VV, Shevchenko AV, Tyan NV. Serum levels and genetic variants of inflammatory cytokines are associated with coronary artery disease in type 2 diabetic subjects. 76th Scientific Session of American Diabetes Association. New Orleans, USA, June 10-14, 2016.

3. Klimontov VV, Tyan NV, Lykov AP, Bondarenko NA, Myakina NE. Lack of association between production of cytokines, NO, and MMP-9 by peripheral blood mononuclear cells and glycemic variability in type 2 diabetic patient. 76th Scientific Session of American Diabetes Association. New Orleans, USA, June 10-14, 2016.

4. Tyan NV, Klimontov VV, Shevchenko AV, Fazullina ON, Orlov NB, Konenkov VI. Polymorphisms in the gene promoters of IL4, IL6, IL10 and TNFA associated with serum levels of cytokines in type 2 diabetic subjects. 52nd Annual Meeting of the European Association for the Study of Diabetes. Munich, Germany, 12-16 September 2016: PP 1071.

5. Klimontov VV, Tyan NV, Bulumbaeva DM, Orlov NB, Konenkov VI. Serum levels of angiogenic regulators in type 2 diabetic patients: the relationships with cardiovascular complications. 52nd Annual Meeting of the European Association for the Study of Diabetes. Munich,
Germany, 12-16 September 2016: PP 1129.

6. Gavrilova YuS, Bgatova NP, Korbut AI, Klimontov VV, Ischenko IYu, Myakina NE, Michurina SV, Zavyalov EL. Linagliptin alleviates podocyte injure and increases glomerular nephrin expression in a model of type 2 diabetic nephropathy. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Abstract Book. Novosibirsk, 30-31 August 2016.

7. Klimontov VV, Shevchenko AV, Prokofiev VF, Tyan NV, Konenkov VI. Combinations of polymorphisms in cytokine and matrix metalloproteinase genes are associated with chronic kidney disease in type 2 diabetic subjects. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”.Novosibirsk, 30-31 August 2016.

8. Klimontov VV, Tyan NV, Shevchenko AV, Prokofiev VF, Lykov AP, Konenkov VI. Immunogenetic factors associated with chronic low-grade inflammation in type 2 diabetic subjects. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Novosibirsk, 30-31 August 2016.. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”.Novosibirsk, 30-31 August 2016.

9. Klimontov VV, Tyan NV, Shevchenko AV, Prokofiev VF, Fazullina ON, Konenkov VI. Single-nucleotide polymorphisms in promoters of cytokine genes are associated with serum cytokine levels in type 2 diabetic patients. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Novosibirsk, 30-31 August 2016.

10. Klimontov VV, Bulumbaeva DM, Tyan NV, Orlov NB, Lykov AP, Konenkov VI. Inverse changes in serum concentrations of inflammatory and angiogenic mediators in patients with type 2 diabetes. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Novosibirsk, 30-31 August 2016.

11. Michurina SV, Ischenko IJu, Klimontov VV, Archipov SA, Cherepanova MA, Rachkovskaya LN, Myakina NE, Zavjalov EL, Konenkov VI, Borodin JuI, Korolev MA. Effects of the complex of melatonin, aluminium oxide and polymethylsiloxane on the liver structure in type 2 diabetic mice. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Novosibirsk, 30-31 August 2016.

12. Myakina NE, Tabakov KA, Klimontov VV. Random forest algorithm provides accurate prediction of glucose trends in diabetic subjects. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”. Novosibirsk, 30-31 August 2016.

13. Myakina NE, Klimontov VV. Algorithmic adjustment of insulin regimen reduces glucose variability in patients with type 1 diabetes in hospital settings. The International Symposium “Systems Biology and Biomedicine (SBioMed-2016)”.Novosibirsk, 30-31 August 2016.

14. Koroleva EA, Klimontov VV, Bulumbaeva DM. The treatment of MODY1 with combination of gliclazide and dapagliflozin: a case report. IV EASD Postgraduate Course on Clinical Diabetes.Vladivostok, Russia, April 21-23, 2016.

2015

1. Klimontov VV, Bgatova NP, Gavrilova JuS, Ischenko IJu, Myakina NE, Michurina SV, Zavjalov EL. Linagliptin allieviate renal injury in a model of type 2 diabetic nephropathy. 75th Scientific Session of American Diabetes Association.Boston, June 5-9, 2015. 563-P

2. Myakina NE, Klimontov VV, Safarov DM. Glucose fluctuations аnd heart rate variability in tуре 2 diabetic patients: The Results of simultaneous glucose and ECG monitoring. 75th Scientific Session of American Diabetes Association.Boston, June 5-9, 2015. 653-P

3. Myakina NE, Klimontov VV. Nocturnal hypoglycemia can be predicted by retrospective analysis of glucose variability in elderly type 2 diabetic patients treated by insulin. 51th Annual Meeting of the European Association for the Study of Diabetes. Stockholm,2015. PP 864.

4. Klimontov VV, Myakina NE, Tyan NV. Systemic inflammation and glucose variability in type 2 diabetic patients with and without chronic kidney disease. 51th Annual Meeting of the European Association for the Study of Diabetes. Stockholm,2015. PP 1133.

2014

1. Tabakov K, Myakina N. Glucose trend prediction in diabetic patients using Random Forests algorithm for analysis of CGM data. 50th Annual Meeting of the European Association for the Study of Diabetes. Vienna,2014. PP 996.

2013

1. Klimontov VV, Tsiberkin AI, Fazullina ON, Prudnikova MA, Tyan NV, Konenkov VI. Glucose variability and hypoglycaemic excursions in elderly type 2 diabetic patients treated with insulin. 49th Annual Meeting of the European Association for the Study of Diabetes. Barcelona,2013. PP 590.

2. Klimontov VV, Bondar IA, Parfentjeva EM, Romanov VV, Bgatova NP. Urinary excretion of site-specific tubular markers in patients with type 1 diabetes. World Diabetes Congress. Melbourne, 2013.